Fusidic acid sodium salt CAS:751-94-0
Fusidic acid sodium salt is utilized in medical practice for the treatment of various bacterial infections, including skin and soft tissue infections, bone and joint infections, and respiratory tract infections caused by susceptible organisms. It can be administered orally, topically, or intravenously, depending on the type and severity of the infection. In dermatology, fusidic acid sodium salt is often prescribed in cream or ointment form for the treatment of impetigo, infected wounds, eczema, and other skin conditions. The topical application allows for targeted delivery of the antibiotic to the site of infection. For systemic infections, healthcare providers may recommend oral or intravenous administration of fusidic acid sodium salt to manage more severe bacterial infections. Dosage regimens are individualized based on factors such as the type of infection, patient's age, weight, renal function, and susceptibility testing results if available. Adherence to the prescribed dosages and completion of the full course of treatment are essential to ensure effective microbial eradication and minimize the risk of recurrent infections or antibiotic resistance. Patients should follow their healthcare provider's instructions closely and report any adverse reactions during treatment. Regular monitoring by healthcare professionals is important to assess treatment response, monitor for potential side effects, and adjust therapy as needed. Collaboration between patients, caregivers, and healthcare providers is crucial for optimal outcomes when using fusidic acid sodium salt in the management of bacterial infections.
Composition | C31H49NaO6 |
Assay | 99% |
Appearance | white powder |
CAS No. | 751-94-0 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |